A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy

Kaho Sugahara(Hamanomachi Hospital), Toyoshi Yanagihara(Hamanomachi Hospital), Yuri Nakamura(Fukuoka Hospital), Yuuka Nakayama(Hamanomachi Hospital), Katsuzo Hanaoka(Hamanomachi Hospital), Migiwa Ohgushi(Hamanomachi Hospital), Naruhiko Ogo(Hamanomachi Hospital), Yu Inutsuka(Hamanomachi Hospital), Tatsuma Asoh(Hamanomachi Hospital), Yukiko Harada(Hamanomachi Hospital), Reiko Yoneda(Hamanomachi Hospital), Takashige Maeyama(Hamanomachi Hospital)
Cureus
December 10, 2021
Cited by 1Open Access
Full Text

Abstract

We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillus species. Since antibiotic treatment alone failed to resolve the infection, percutaneous drainage of the infected bulla was performed. Although a prolonged treatment period was necessary, the infected lung bulla and the lung abscess were eventually resolved. During her illness, the patient also developed arthritis, possibly related to the HTLV-1 infection. Thus, persons infected with HTLV-1 can develop refractory infections, myelopathy, and arthritis. Percutaneous drainage is an option to treat refractory infected lung bullae.


Related Papers

No related papers found

Powered by citation graph analysis